US20020177889A1 - Ballon catheters having ultraonically driven interface surfaces and methods for their use - Google Patents

Ballon catheters having ultraonically driven interface surfaces and methods for their use Download PDF

Info

Publication number
US20020177889A1
US20020177889A1 US10/179,669 US17966902A US2002177889A1 US 20020177889 A1 US20020177889 A1 US 20020177889A1 US 17966902 A US17966902 A US 17966902A US 2002177889 A1 US2002177889 A1 US 2002177889A1
Authority
US
United States
Prior art keywords
catheter
balloon
interface surface
angioplasty
balloons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/179,669
Inventor
Axel Brisken
Vartan Ghazarossian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmasonics Inc
Original Assignee
Pharmasonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/708,589 priority Critical patent/US5846218A/en
Priority to US09/205,061 priority patent/US6287272B1/en
Priority to US09/808,725 priority patent/US6464660B2/en
Application filed by Pharmasonics Inc filed Critical Pharmasonics Inc
Priority to US10/179,669 priority patent/US20020177889A1/en
Publication of US20020177889A1 publication Critical patent/US20020177889A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty

Abstract

A catheter comprises a catheter body having an oscillating driver, an interface surface mechanically coupled to the driver, and an inflatable balloon disposed near the interface surface. The balloon may be an angioplasty balloon, in which case the interface surface will deliver ultrasonic or other vibratory energy into a blood vessel as part of an angioplasty or related procedure. Alternatively, the catheter may comprise a pair of axially spaced-apart isolation balloons, in which case the interface surface can deliver ultrasonic or other vibratory energy into a treatment region defined between said balloons. The energy can thus act to mix or enhance penetration of a treatment held between said balloons in performing a vascular treatment procedure.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • The present application is a continuation of application Ser. No. 09/808,725 (Attorney Docket No. 017148-000720), filed on Mar. 14, 2001, which was a continuation application Ser. No. 09/205,061 (Attorney Docket No. 017148-0007100) filed on Dec. 4, 1998 (now U.S. Pat. No. 6,287,272), which was a continuation-in-part of application Ser. No. 08/708,589, (Attorney Docket No. 017148-000700), filed on Sep. 5, 1996, now U.S. Pat. No. 5,846,218. The full disclosures of each of these applications is incorporated herein by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated. [0003]
  • Despite the growing sophistication of medical technology, vascular (blood vessel) diseases, such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries), remain a frequent, costly, and very serious problem in health care. Current methods of treatment, often expensive, are not always effective. In the U.S. alone, the cost of treatment and support and the loss of productivity due to vascular diseases together exceed $40 billion per year. [0004]
  • The core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood. Current treatments include drugs, interventional devices, and/or bypass surgery. High doses of thrombolytics (clot-dissolving drugs) are frequently used in an effort to dissolve the blood clots. Even with such aggressive therapy, thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients. In addition, these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications. [0005]
  • While a variety of interventional devices are available, including angioplasty, atherectomy, and laser ablation catheters, the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar. The scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis). Also, diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention. Approximately 40% of treated patients require additional treatment for restenosis resulting from scar formation occurring over a relatively long period, typically 4 to 12 months, while approximately 1-in-20 patients require treatment for vasoconstriction, which typically occurs from 4 to 72 hours after the initial treatment. [0006]
  • The use of ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis. Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends. [0007]
  • It would be desirable to provide improved devices, systems, and methods, for treating vascular diseases, particularly stenotic diseases which occlude the coronary and other arteries. In particular, it would be desirable to provide methods and devices for enhancing the performance of angioplasty procedures, where the ability to introduce an angioplasty catheter through a wholly or partly obstructed blood vessel lumen can be improved. Moreover, it would be desirable to provide mechanisms as part of an angioplasty catheter, which mechanisms can assist in initial balloon deployment and/or decrease the likelihood of subsequent clot formation and restenosis. The devices, systems, and methods, should further be useful with other procedures which employ balloon catheters, including stent deployment and drug delivery, where drug delivery can be achieved by deploying a pair of spaced-apart balloons for defining a treatment region therebetween. [0008]
  • The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated. [0009]
  • Despite the growing sophistication of medical technology, vascular (blood vessel) diseases, such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries), remain a frequent, costly, and very serious problem in health care. Current methods of treatment, often expensive, are not always effective. In the U.S. alone, the cost of treatment and support and the loss of productivity due to vascular diseases together exceed $40 billion per year. [0010]
  • The core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood. Current treatments include drugs, interventional devices, and/or bypass surgery. High doses of thrombolytics (clot-dissolving drugs) are frequently used in an effort to dissolve the blood clots. Even with such aggressive therapy, thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients. In addition, these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications. [0011]
  • While a variety of interventional devices are available, including angioplasty, atherectomy, and laser ablation catheters, the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar. The scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis). Also, diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention. Approximately 40% of treated patients require additional treatment for restenosis resulting from scar formation occurring over a relatively long period, typically 4 to 12 months, while approximately 1-in-20 patients require treatment for vasoconstriction, which typically occurs from 4 to 72 hours after the initial treatment. [0012]
  • The use of ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis. Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends. [0013]
  • It would be desirable to provide improved devices, systems, and methods, for treating vascular diseases, particularly stenotic diseases which occlude the coronary and other arteries. In particular, it would be desirable to provide methods and devices for enhancing the performance of angioplasty procedures, where the ability to introduce an angioplasty catheter through a wholly or partly obstructed blood vessel lumen can be improved. Moreover, it would be desirable to provide mechanisms as part of an angioplasty catheter, which mechanisms can assist in initial balloon deployment and/or decrease the likelihood of subsequent clot formation and restenosis. The devices, systems, and methods, should further be useful with other procedures which employ balloon catheters, including stent deployment and drug delivery, where drug delivery can be achieved by deploying a pair of spaced-apart balloons for defining a treatment region therebetween. [0014]
  • 2. Description of the Background Art [0015]
  • A catheter system having a pair of spaced-apart balloons with a coiled piezoelectric strip therebetween is described in U.S. Pat. No. 5,279,546. Catheters having elongate ultrasonic transmission elements and inflatable cuffs are described in U.S. Pat. Nos. 5,397,301; 5,304,115; and 4,870,953. A tunneling catheter having a radiofrequency, laser, or ultrasonic active distal end disposed within an angioplasty catheter is described in EP 189 329. An atherectomy catheter having an ultrasonically enhanced blade disposed adjacent an asymmetrically mounted balloon is described in U.S. Pat. No. 5,085,662. Phonophoresis transducers disposed within porous, inflatable balloons are suggested in U.S. Pat. Nos. 5,286,254 and 5,282,785. Other catheters having ultrasonic elements with the capability of delivering thrombolytic and other liquid agents are described in U.S. Pat. Nos. 5,362,309; 5,318,014; 5,315,998; 5,197,946; 5,380,273; 5,344,395; 5,342,292; 5,324,255; 5,269,297; 5,267,954; 4,808,153; 4,692,139; and 3,565,062; in WO 90/01300; and in Tachibana (1992) JVIR 3:299-303. A rigid ultrasonic probe intended for treating vascular plaque and having fluid delivery means is described in U.S. Pat. No. 3,433,226. An ultrasonic transmission wire intended for intravascular treatment is described in U.S. Pat. No. 5,163,421 and Rosenschein et al. (1990) JACC 15:711-717. Ultrasonic enhancement of systemic and localized drug delivery is described in U.S. Pat. Nos. 5,267,985; and 4,948,587; in WO 94/05361 and WO 91/19529; in JP 3-63041; and Yumita et al. (1990) Jpn. J. Cancer Res. 81:304-308. An electrosurgical angioplasty catheter having ultrasonic enhancement is described in U.S. Pat. No. 4,936,281. An infusion and drainage catheter having an ultrasonic cleaning mechanism is described in U.S. Pat. No. 4,698,058. Angioplasty balloon catheters having axial blade atherectomy, ultrasonic imaging, and rotary blade atherectomy devices at their distal ends are described in U.S. Pat. Nos. 5,053,044; 5,117,831; and 5,181,920, respectively. [0016]
  • This application is related to the following commonly assigned patents and applications: U.S. Pat. Nos. 5,725,494; 5,728,062; 5,735,811; 5,931,805; Ser. Nos. 09/033,834; 09/223,230; 09/635,033; and 09/653,678. The full disclosures of each of these patents and pending applications are incorporated herein by reference. [0017]
  • BRIEF SUMMARY OF THE INVENTION
  • According to the present invention, improved devices and systems are provided which combine both an inflatable balloon and an axially oscillated interface surface on a single catheter device. The devices and systems are useful for a number of intervascular procedures, including ([0018] 1) angioplasty and related procedures, such as stent deployment, where ultrasonic energy delivered by the interface surface can soften the stenotic material in the blood vessel to facilitate deployment and initial treatment and can also reduce residual clot in the treated region in order to lessen the likelihood of restenosis, and (2) drug delivery methods where balloons are used to isolate a treatment region and at least one of the balloons is coupled to the interface surface so that oscillation of the balloon(s) enhances mixing and penetration of a treatment medium localized between the balloons.
  • The catheters of the present invention will comprise a catheter body having a proximal end and a distal end. An oscillating driver is disposed at or near the distal end of the catheter body, and an interface surface is mechanically coupled to the driver so that the surface can be axially oscillated relative to the catheter body. An inflatable balloon is also disposed on the catheter body near the interface surface, where the balloon can be used for angioplasty, stent deployment, or the like, and optionally can be combined with a second balloon to define a drug treatment region therebetween. [0019]
  • In a first specific embodiment, the interface surface comprises a distal tip which extends laterally over the distal end of the catheter body. An angioplasty or stent delivery balloon is disposed on the catheter body proximal to the interface surface. Optionally, the interface surface can further include a cylindrical portion which extends over an axial surface of the catheter body. In either case, a distal end of the balloon can be secured directly to the interface surface so that the balloon itself is caused to directly oscillate as the interface surface is oscillated by the driver. [0020]
  • In use, the catheters having interface surfaces including a laterally disposed distal tip will facilitate penetration of the catheter through a partly or wholly occluded stenotic region within a blood vessel. The distal tip will be driven, and the catheter advanced through the stenotic material, with the ultrasonic energy softening the stenotic material to facilitate advance of the catheter. The balloon, which is proximal to the distal tip, may then be used for either an angioplasty procedure, stent delivery, or both. In either case, the interface surface on the catheter can thereafter be used to further treat the stenotic region with ultrasonic energy to reduce the amount of clot remaining in order to lessen the likelihood of further clot formation and restenosis. [0021]
  • In a second specific embodiment, the interface surface is disposed at least partly within the inflatable balloon on the catheter body. Preferably, the interface surface and associated oscillatory driver are both located entirely within the inflatable balloon, so that the interface surface can be used to transfer ultrasonic energy directly into the inflation medium used to inflate the balloon. Alternatively, the balloon is mounted so that at least one of its forward end and/or distal end is secured to a cylindrical interface surface. In this way, after balloon inflation, the interface surface will directly oscillate one or both ends of the balloon. The catheters of this type will be particularly useful for performing enhanced angioplasty procedures, optionally with stent delivery. [0022]
  • A third exemplary embodiment of the catheter of the present invention comprises a pair of spaced-apart inflatable balloons on the catheter body. A cylindrical interface surface is disposed between the balloons, with at least one of the distal end of the proximal-most balloon and the proximal end of the distal-most balloon being secured to the interface member. A fluid delivery lumen is provided within the catheter so that a treatment medium can be delivered to the region between the balloons when the balloons are expanded in a blood vessel. Mixing and/or penetration of the treatment medium is enhanced by ultrasonic oscillation of the cylindrical interface surface when the treatment medium is present.[0023]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates an exemplary catheter incorporating an interface surface having a distal tip and an angioplasty balloon disposed proximally of the interface surface, constructed in accordance with the principles of the present invention. [0024]
  • FIG. 2 is a detailed view of the distal end of the catheter of FIG. 1, shown in partial section. [0025]
  • FIG. 3 is a detailed view of the distal end of a first alternative embodiment of the catheter of FIG. 1, wherein the interface surface further extends over a cylindrical portion of the catheter body, shown in partial section. [0026]
  • FIG. 4 is a detailed view of the distal end of a second alternative embodiment of the catheter of FIG. 1, wherein the angioplasty balloon is attached at its distal end to the interface surface. [0027]
  • FIG. 5 is a detailed view of the distal end of a third alternative embodiment of the catheter of FIG. 1, wherein the distal end of the angioplasty balloon is attached to the cylindrical portion of the interface surface of the first alternative embodiment of FIG. 2. [0028]
  • FIGS. [0029] 6-8 illustrate use of the catheter of FIG. 2 for penetrating a stenotic region within a blood vessel and expanding a vascular stent therein.
  • FIG. 9 illustrates the distal end of a fourth alternative embodiment of the catheter of the present invention, wherein a cylindrical interface surface is disposed entirely within an angioplasty balloon. [0030]
  • FIG. 10 illustrates a fifth alternative embodiment of the catheter of the present invention, wherein the angioplasty balloon is attached at both its proximal and distal ends to a cylindrical interface surface. [0031]
  • FIG. 11 is a view of the distal end of the catheter of FIG. 9, shown in partial section. [0032]
  • FIGS. 12 and 13 illustrate use of the catheter of FIG. 9 for expanding a stent within a stenotic region in a blood vessel. [0033]
  • FIG. 14 illustrates a sixth alternative embodiment of the catheter of the present invention, wherein the catheter includes a pair of axially spaced-apart balloons and wherein the distal end of the proximal-most balloon and the proximal end of the distal-most balloon are each attached to a cylindrical interface surface disposed therebetween.[0034]
  • DESCRIPTION OF THE SPECIFIC EMBODIMENTS
  • The present invention provides apparatus and methods for the treatment of luminal conditions, particularly for the treatment of diseases of the coronary and peripheral vasculature. Specific conditions include coronary and peripheral arterial disease and thrombosis. The apparatus and methods are useful for primary treatment of such diseases, where the purpose is to ablate, dissolve, or otherwise disrupt the clot, plaque, or other stenotic lesions which are responsible for the disease. For example, catheters constructed according to the principles of the present invention can be used to directly engage and transmit vibratory, usually ultrasonic, energy into the stenotic material in order to mechanically disrupt the material to open the associated blood vessel lumen. The catheters of the present invention will also include at least one inflatable balloon in order to perform procedures which combine use of the balloon with the ability to deliver ultrasonic or other vibratory energy. [0035]
  • Usually, the balloons will be angioplasty balloons useful for engaging and dilatating stenotic regions within a blood vessel. In such cases, the vibratory energy may be used either to enhance initial penetration of the catheter so that the angioplasty balloon can be positioned within the stenotic region (e.g. by softening or disrupting the stenotic material prior to balloon positioning), to soften the stenotic material while the balloon is being expanded with or without a stent, and/or to treat the stenotic region within the blood vessel after the balloon has been used to perform angioplasty, stent placement, or the like. In the latter case, the transfer of ultrasonic energy can reduce the presence of residual clot which can serve as nuclei for subsequent clot formation and restenosis. [0036]
  • The catheters may also include a pair of spaced-apart balloons, where the balloons define a treatment region therebetween which is useful to enhance the administration of therapeutic agents, where the therapeutic agents are primarily responsible for the disruption of the stenotic material and/or lessening of restenosis subsequent to angioplasty. In such cases, the vibratory energy will be relied on to agitate and promote the penetration of the therapeutic agent into the stenotic material. Suitable therapeutic agents include known thrombolytic and fibrinolytic drugs, such as heparin, tissue plasminogen activator (tPA), urokinase, streptokinase, and the like. [0037]
  • The catheters of the present invention will comprise a catheter body having a proximal end and distal end. The catheter body will have dimensions and physical characteristics selected for the particular use. For vascular applications, the length of the catheter body will typically be from 50 cm to 200 cm, usually being from 75 cm to 150 cm, and the diameter will be from 1 mm to 5 mm, usually being from 2 mm to 4 mm. The diameter of the catheter body may vary over its length, and different portions of the length may be formed from different materials. In the exemplary embodiment, the catheter body will comprise a single extrusion having at least one lumen therethrough for providing an inflation medium to the balloon. That or another lumen, will usually be capable of receiving a guidewire, and may also be capable of delivering therapeutic agents and/or carrying electrical wires for connection from the proximal end of the catheter body to the distal end. Alternatively, the catheter body may include separate lumens for balloon inflation, delivering therapeutic agent(s), routing electrical wires for connection to the ultrasonic transducer, or other purposes. [0038]
  • The catheter body may be reinforced over all or a portion of its length. Conventional reinforcement materials include wire braids, wire meshes, wire coils, helical ribbons, and the like. [0039]
  • When employed with a guidewire for placement within the vasculature, the catheter body may have an “over-the-wire” design or a “rapid exchange” design. In the former case, the guidewire lumen will extend substantially through the entire length of the catheter body. In the latter case, the guidewire lumen will terminate in a proximal guidewire port located relatively near the distal end of the catheter body, usually within 50 cm, more usually within 30 cm, and often within 25 cm or less. Usually, a proximal housing will be secured to the proximal end of the catheter body, where the housing includes a guidewire port, a therapeutic agent infusion port, an electrical connector, and the like. [0040]
  • A longitudinally vibrating assembly is secured at or near the distal end of the catheter body. The assembly will include at least one interface surface, usually present on an interface member, which is vibrated at a desired frequency, wherein the interface surface is oriented to transmit vibrations to the fluid environment surrounding the distal end of the catheter. The vibrating assembly will usually be attached directly to the distal end of the catheter body but also could be disposed partially or totally within the distal end of the catheter body. Usually, the vibrating assembly will have a relatively short length, typically being below 2 cm, preferably being below 1 cm, and typically being in the range from about 0.4 cm to 1.5 cm, more usually in the range from about 0.6 cm to 1 cm. The assembly will preferably have a low profile (narrow diameter) to facilitate vascular or other intraluminal introductions, typically having a diameter below 6 mm, usually in the range from 1 mm to 5 mm, more usually in the range from 2 mm to 4 mm. [0041]
  • In a first exemplary embodiment of the present invention, the interface surface will be forwardly disposed so that the surface may engage intraluminal obstructions as the catheter is advanced through the body lumen, such as a blood vessel. In a second exemplary embodiment, the interface member may also or alternatively include an interface surface where at least a portion of the surface is disposed circumferentially about the catheter body. The circumferential portion will usually be a cylinder, and the interface member and surface will oscillate axially (i.e., back and forth generally in the direction of the catheter body). The energy will radiate away from the cylindrical surface of the interface member in a generally uniform pattern, i.e., isotropically (radially outward). Such uniform radiation is particularly advantageous for softening stenotic material and/or for enhancing the penetration of therapeutic agents into a length of an intraluminal wall adjacent a cylindrical interface surface. [0042]
  • In the exemplary embodiments, the cylindrical interface surface will typically have a length in the range from 4 mm to 30 mm, preferably from 6 mm to 15 mm. The outer diameter of the cylindrical surface will typically be in the range from 2 mm to 5 mm, more usually from 3 mm to 4 mm. The interface member may further include a forwardly disposed lateral surface, typically being formed laterally at the distal end of the cylindrical surface. The lateral surface may itself be flat, convex (in the form of a forwardly disposed dome at the distal end of the cylindrical surface), concave, or irregular. The cylindrical surface and/or the forwardly disposed lateral surface may also have surface irregularities formed therein. For example, a plurality of ridges, protrusions, or the like, may be provided for enhancing the transfer of oscillatory motion into the fluid adjacent the surface. [0043]
  • An oscillating driver will be provided on the catheter body for oscillating the interface member in a desired manner. Usually, the driver will be separate from the interface member. In some cases, however, it may be possible to provide an oscillatory driver which also defines the interface surface, particularly for radially oscillating drivers as described in copending application Ser. Nos. 08/565,575; 08/566,739; and 08/566,740, the full disclosures of which have previously been incorporated herein by reference. The drivers will usually be ultrasonic transducers, including tubular piezoelectric transducers, piezoelectric stack transducers, magnetostrictive drivers, dectostrictive drivers, or the like. Optionally, the drivers may be incorporated in a resonant drive assembly, typically including a spring element attaching the interface member to the catheter body, where the ultrasonic driver is a longitudinally oscillating driver disposed between the catheter body and the interface member. Longitudinally oscillating drivers will usually be selected to oscillate with an amplitude in the range from 0.05 μm to 50 μm, often from 0.1 μm to 20 μm, preferably from 0.5 μm to 4 μm. The details of such drivers and resonant drive assemblies are set forth in copending application Ser. No. 08/565,575, assigned to the assignee of the present application, the full disclosure of which is incorporated herein by reference. [0044]
  • The catheters of the present invention will further comprise expansible balloon members disposed proximally and/or distally of the interface surface(s) of the interface member. The expansible members, typically in the form of inflatable non-compliant and/or elastomeric balloons, may be utilized to perform angioplasty or engage a luminal wall to isolate a luminal region to be treated. Materials and designs for incorporating balloons in intravascular and other catheters are well known in the art. [0045]
  • Referring now to FIG. 1, a catheter system [0046] 10 comprising a catheter 12 constructed in accordance with the principles of the present invention and a power supply 14 is illustrated. The catheter 12 includes a catheter body 16 having a distal end 18 and a proximal end 20, and a proximal housing 22 having a balloon inflation port 24 and a guidewire port 26. Usually, the catheter 12 will have at least a second lumen (not illustrated) for accommodating wires transmitting energy from the power supply 14 to an ultrasonic transducer, as described hereinafter. Cable 30 extends from the proximal end 20 of the catheter body 16 and includes a connector 32 which mates with connector 32 a on cable 33 from the power supply 14. The power supply 14 will be selected to provide an appropriate current source for driving an ultrasonic transducer, as described in more detail herein below.
  • The power supply and transducer will be selected so that the ultrasonic driver typically operates in the range from 1 kHz to 300 kHz, preferably from 20 kHz to 80 kHz. For example, the power supply [0047] 14 may comprise a conventional signal generator, such as those commercially available from suppliers such as Hewlett-Packard, Palo Alto, Calif., and Tektronics, Portland, Oreg., and a power amplifier, such as those commercially available from suppliers such as ENI, Rochester, N.Y., and Krohn-Hite Corporation, Avon, Mass.
  • Referring now to FIGS. 1 and 2, the catheter [0048] 12 includes a vibratory assembly 40 at its distal end 18. The vibratory assembly 40 includes a distal tip 42 connected to a tail mass 44 by a spring member 46. Conveniently, the distal tip 42, tail mass 44, and connecting spring 46 may be integrally formed, although such integral construction is not a requirement for the present invention. An oscillatory drive assembly 50 is disposed between a proximal surface of the distal tip 42 and a distal surface of the tail mass 44, and may comprise a cylindrical piezoelectric element, such as those described in copending application Ser. Nos. 08/565,575 and 08/566,739, the full disclosures of which have been incorporated herein by reference. Other longitudinal drivers, such as stacked piezoelectric disks and magnetostrictive drivers (as described in copending application Ser. No. 08/566,740, the full disclosure of which has previously been incorporated herein by reference), may also find use. The vibratory assembly 40 will be able to longitudinally oscillate the distal tip 42 so that a forwardly disposed lateral surface 52 may be longitudinally oscillated, typically with an amplitude in the range from 0.05 μm to 20 μm.
  • An angioplasty balloon [0049] 60 is disposed on the catheter body 12 proximal to the distal tip 42, typically being spaced-apart from the tip by a length in the range from 0 mm to 30 mm, typically from 2 mm to 10 mm. The balloon 60 may be inflated through an inflation port 62 which is connected to inflation port 24 on the proximal housing 22.
  • The distal end of an alternative embodiment of the catheter of FIG. 1 is illustrated in FIG. 3. There, a vibratory assembly [0050] 70 at the distal end 18 (all common elements of the alternative embodiment will be given the same reference numbers) of the catheter body 12. The vibratory assembly 70 includes a tail mass 44, and a spring 46, each of which are identical to the same elements in the catheter of FIGS. 1 and 2. Instead of the distal tip 42, the catheter of FIG. 3 includes an interface surface comprising a cylindrical interface surface which extends over a length of the catheter body from 4 mm to 30 mm, preferably from 6 mm to 15 mm. The distal end of the interface surface terminates in a lateral surface 52 which may have generally the same geometry as that of the catheter of FIGS. 1 and 2. The oscillatory driver 50 will generally be the same as that described previously.
  • The primary difference between the vibratory assembly [0051] 40 and vibratory assembly 70 is in the nature of the interface surface. The interface surface defined by distal tip 42 and FIGS. 1 and 2 provides only a forwardly disposed, lateral interface 52 surface which is useful for engaging stenotic material directly in front of the catheter. While the vibratory assembly 70 includes an equivalent forwardly disposed interface surface, it further includes a circumferentially disposed cylindrical surface which can impart vibratory energy radially outwardly into fluid surrounding the catheter tip. The nature and advantages of such cylindrical and other laterally disposed interface surfaces are described in more detail in copending application Ser. No. 08/566,739, the full disclosure of which has previously been incorporated herein by reference.
  • The catheters of FIGS. [0052] 1-3 each attach the angioplasty balloon directly to the catheter body. Thus, vibration of the interface surfaces of those catheters is not directly coupled to the balloon itself. Referring now to FIGS. 4 and 5, angioplasty balloons may be partly or wholly connected to the interface surfaces which are vibrated by the oscillatory drivers. For example, as illustrated in FIG. 4, a balloon 80 may be attached at its proximal end 82 to the catheter body 12 and at its distal end 84 to the distal tip 42. In this way, the distal end of the balloon 80 may be directly vibrated by the distal tip 42 in order to impart oscillatory energy to the balloon. The balloon may thus be directly vibrated and enhance the transfer of oscillatory energy into the fluid medium surrounding the catheter. Similarly, a balloon 90 may have its distal end 94 attached to the cylindrical interface surface 72 of the catheter of FIG. 3, as illustrated in FIG. 5.
  • Referring now to FIGS. [0053] 6-8, the catheter of FIG. 3 may be used to perform angioplasty and optionally deliver a stent ST. Initially, the catheter is delivered over a guidewire GW until the distal interface surface 52 of the catheter engages the stenotic material S within a blood vessel BV. The oscillatory driver of the catheter is then actuated so that the distal surface 52 is longitudinally oscillated in order to soften the stenotic material S and enhance penetration of the catheter through the stenotic material. In particular, ultrasonic energy may be radiated forwardly in a pattern indicated by wave front lines 74, as shown in FIG. 6.
  • After the catheter has penetrated the material in the stenotic region S, the balloon [0054] 60 may be inflated, optionally expanding the stent ST, as illustrated in FIG. 7. After the region has been dilatated, and optionally the stent ST delivered, the catheter may be moved rearwardly so that the cylindrical surface 72 is aligned with the region that has been treated, as illustrated in FIG. 8. The catheter may again be actuated, and the cylindrical surface 72 will transfer ultrasonic wave energy into the medium surrounding the distal end of the catheter, as illustrated by the laterally extending transverse wave lines 73 from the surface. The ultrasonic energy will further reduce any residual clot or other stenotic materials which may be present after the dilatation in order to reduce the likelihood of restenosis.
  • Referring now to FIGS. [0055] 9-11, further alternative embodiments of the catheter of the present invention will be illustrated. In FIG. 9, a cylindrical interface surface 100 is disposed completely within inflatable angioplasty balloon 102. An inflation port 104 is provided on the catheter body 106, and actuation of the oscillatory driver, as illustrated in FIG. 11, will impart transverse waves into the inflation medium within the balloon 102. In FIG. 10, a balloon 110 is attached at both its distal and proximal ends to a cylindrical interface surface 112. In this way, when the interface surface 112 is actuated, both ends of the balloon 112 will be longitudinally oscillated together with the surface.
  • Referring now to FIG. 11, a first tubular transducer [0056] 120 and a second tubular transducer 122 are disposed on the proximal and distal sides of a flange 124 which is located in the middle of a tubular holder 126. As illustrated, the transducers 120 and 122 are tubular piezoelectric transducers, but they could also be piezoelectric stack transducers, magnetostrictive drivers, or the like, as described in more detail in copending application Ser. Nos. 08/565,575; 08/566,739; and 08/566,740, the full disclosures of which have previously been incorporated herein by reference. In all cases, the transducers 120 and 122 will be wired so that they oscillate longitudinally in the same direction, but 180 out of phase. In this way, the total distance between the proximal end of transducer 120 and the distal end of transducer 122 will remain constant, while the ends of each transducer are displaced axially in a synchronous manner. An interface member 130 having the cylindrical interface surface 100 is attached to the respective ends of the first transducer 120 and the second transducer 122. In this way, the transducers will be driven in a longitudinally oscillating manner at a frequency determined by the characteristics of the transducers and the mass of the interface surface.
  • Referring now to FIGS. 12 and 13, the catheter of FIGS. 9 and 11 may be used to dilatate and optionally deliver a stent to a region of vascular stenosis S in a blood vessel BV. Initially, the balloon [0057] 102 carrying the stent ST is positioned within the region of stenosis S, and thereafter the balloon is inflated, as illustrated in FIG. 12. In order to further inflate the balloon and implant the stent ST, the transducers 120 and 122 are activated in order to longitudinally oscillate the cylindrical surface 102. Such oscillation induces transverse waves within the inflation medium within the balloon 102 as illustrated in FIG. 13. The energy will be further transferred into the blood vessel wall, softening the stenotic material and enhancing expansion of the balloon 102 and stent ST.
  • Referring now to FIG. 14, a catheter [0058] 150 having a proximal balloon 152 and a distal balloon 154 is illustrated. The balloons are axially spaced-apart, and a cylindrical interface surface 156 is disposed therebetween. The interface surface 156 may be constructed identically to the transducer assembly of FIG. 11, except that a fluid transfer port 158 will be provided in order to deliver a treatment medium to the volume between the spaced-apart balloons 152 and 154. In use, the spaced-apart balloons 152 and 154 will be inflated within a blood vessel BV to define a treatment region R therebetween. A liquid treatment medium is then introduced into the treatment region R through the delivery port 158. After the treatment medium is delivered to the treatment region, the cylindrical interface surface will be longitudinally oscillated in order to transfer transverse waves into the medium. The distal end of the proximal balloon 152 and proximal end of the distal balloon 154 are secured to opposite ends of the cylindrical interface surface 156. In this way, the inwardly disposed surfaces of each balloon are oscillated together with the interface surface 156. Thus, the balloons themselves can further act to impart vibratory energy into the treatment medium contained within the treatment region R.
  • Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. [0059]

Claims (1)

What is claimed is:
1. A method for delivering a stent to a blood vessel, said method comprising:
positioning a catheter carrying a stent within the blood vessel;
inflating a balloon on the catheter within the blood vessel to implant the stent; and
transversely oscillating a transducer disposed within the balloon to deliver oscillatory waves into the blood vessel wall in the region of the stent.
US10/179,669 1996-09-05 2002-06-24 Ballon catheters having ultraonically driven interface surfaces and methods for their use Abandoned US20020177889A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US08/708,589 US5846218A (en) 1996-09-05 1996-09-05 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US09/205,061 US6287272B1 (en) 1996-09-05 1998-12-04 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US09/808,725 US6464660B2 (en) 1996-09-05 2001-03-14 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US10/179,669 US20020177889A1 (en) 1996-09-05 2002-06-24 Ballon catheters having ultraonically driven interface surfaces and methods for their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/179,669 US20020177889A1 (en) 1996-09-05 2002-06-24 Ballon catheters having ultraonically driven interface surfaces and methods for their use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/808,725 Continuation US6464660B2 (en) 1996-09-05 2001-03-14 Balloon catheters having ultrasonically driven interface surfaces and methods for their use

Publications (1)

Publication Number Publication Date
US20020177889A1 true US20020177889A1 (en) 2002-11-28

Family

ID=24846413

Family Applications (4)

Application Number Title Priority Date Filing Date
US08/708,589 Expired - Fee Related US5846218A (en) 1996-09-05 1996-09-05 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US09/205,061 Expired - Fee Related US6287272B1 (en) 1996-09-05 1998-12-04 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US10/179,669 Abandoned US20020177889A1 (en) 1996-09-05 2002-06-24 Ballon catheters having ultraonically driven interface surfaces and methods for their use
US10/210,426 Abandoned US20020188243A1 (en) 1996-09-05 2002-07-31 Balloon catheters having ultrasonically driven interface surfaces and methods for their use

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/708,589 Expired - Fee Related US5846218A (en) 1996-09-05 1996-09-05 Balloon catheters having ultrasonically driven interface surfaces and methods for their use
US09/205,061 Expired - Fee Related US6287272B1 (en) 1996-09-05 1998-12-04 Balloon catheters having ultrasonically driven interface surfaces and methods for their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/210,426 Abandoned US20020188243A1 (en) 1996-09-05 2002-07-31 Balloon catheters having ultrasonically driven interface surfaces and methods for their use

Country Status (7)

Country Link
US (4) US5846218A (en)
EP (1) EP1009298A1 (en)
JP (1) JP2001500036A (en)
AU (1) AU4250897A (en)
BR (1) BR9712006A (en)
CA (1) CA2260842A1 (en)
WO (1) WO1998009571A1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060058708A1 (en) * 2003-12-24 2006-03-16 Gill Heart Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue
US20070078505A1 (en) * 2005-04-05 2007-04-05 Dimitrov Nicolay G Two-balloon catheter device for coronary angioplasty and its use
WO2008138997A1 (en) * 2007-05-16 2008-11-20 Rhinomed Ab Vibration device
US20090312827A1 (en) * 2005-12-23 2009-12-17 C.R. Bard Inc. Balloon catheter with centralized vent hole
US20090312768A1 (en) * 2008-06-13 2009-12-17 Aspen Medtech, Inc. Shockwave balloon catheter system
US20100114020A1 (en) * 2008-11-05 2010-05-06 Daniel Hawkins Shockwave valvuloplasty catheter system
US20100114065A1 (en) * 2008-11-04 2010-05-06 Daniel Hawkins Drug delivery shockwave balloon catheter system
US20110034832A1 (en) * 2009-07-08 2011-02-10 Iulian Cioanta Usage of Extracorporeal and Intracorporeal Pressure Shock Waves in Medicine
WO2012106259A2 (en) * 2011-02-04 2012-08-09 Daniel Hawkins High pressure balloon shockwave catheter and method
US8574247B2 (en) 2011-11-08 2013-11-05 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US20140128963A1 (en) * 2012-11-02 2014-05-08 Medtronic, Inc. Transcatheter Valve Prosthesis Delivery System With Recapturing Feature and Method
US8728091B2 (en) 2012-09-13 2014-05-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
US8747416B2 (en) 2012-08-06 2014-06-10 Shockwave Medical, Inc. Low profile electrodes for an angioplasty shock wave catheter
US9011463B2 (en) 2012-06-27 2015-04-21 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
US9072534B2 (en) 2008-06-13 2015-07-07 Shockwave Medical, Inc. Non-cavitation shockwave balloon catheter system
US9138249B2 (en) 2012-08-17 2015-09-22 Shockwave Medical, Inc. Shock wave catheter system with arc preconditioning
US9198618B2 (en) 2011-12-16 2015-12-01 Chordate Medical Ab Pressure sensing system and method
US9220521B2 (en) 2012-08-06 2015-12-29 Shockwave Medical, Inc. Shockwave catheter
US9474684B2 (en) 2012-03-20 2016-10-25 Chordate Medical Ab Electroactive vibration method
US9486381B2 (en) 2011-12-16 2016-11-08 Chordate Medical Ab ALS treatment
US9522012B2 (en) 2012-09-13 2016-12-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
US9579114B2 (en) 2008-05-07 2017-02-28 Northgate Technologies Inc. Radially-firing electrohydraulic lithotripsy probe
US9579247B2 (en) 2011-12-16 2017-02-28 Chordate Medical Ab Treatment of headache disorders
US9730715B2 (en) 2014-05-08 2017-08-15 Shockwave Medical, Inc. Shock wave guide wire
US9782320B2 (en) 2011-12-16 2017-10-10 Chordate Medical Ab Double stimulation
US9872814B2 (en) 2012-03-20 2018-01-23 Chordate Medical Ag Vibration pattern for vibration stimulation
US9895279B2 (en) 2011-12-16 2018-02-20 Chordate Medical Ab Stimulation of hypothalamus
US10226265B2 (en) 2016-04-25 2019-03-12 Shockwave Medical, Inc. Shock wave device with polarity switching

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US8709007B2 (en) 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6913763B2 (en) * 1996-11-19 2005-07-05 Intrabrain International Nv Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal
US6464660B2 (en) * 1996-09-05 2002-10-15 Pharmasonics, Inc. Balloon catheters having ultrasonically driven interface surfaces and methods for their use
AU775394B2 (en) * 1999-07-19 2004-07-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US20070293855A1 (en) * 2002-02-15 2007-12-20 Sliwa John W Jr Methods and devices for ablation
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6607502B1 (en) 1998-11-25 2003-08-19 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6117101A (en) * 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US6794369B2 (en) * 1997-12-31 2004-09-21 Pharmasonics Methods, systems, and kits for intravascular nucleic acid delivery
AU2023199A (en) * 1997-12-31 1999-07-19 Pharmasonics, Inc. Methods, systems, and kits for intravascular nucleic acid delivery
WO1999033391A2 (en) * 1997-12-31 1999-07-08 Pharmasonics, Inc. Methods and systems for the inhibition of vascular hyperplasia
US6723063B1 (en) 1998-06-29 2004-04-20 Ekos Corporation Sheath for use with an ultrasound element
US6148222A (en) * 1998-07-10 2000-11-14 Cardiocommand, Inc. Esophageal catheters and method of use
US6135976A (en) * 1998-09-25 2000-10-24 Ekos Corporation Method, device and kit for performing gene therapy
US6317615B1 (en) 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
US6758830B1 (en) 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
ES2279757T3 (en) 1999-05-11 2007-09-01 Atrionix, Inc. Balloon anchor wire.
US6398792B1 (en) * 1999-06-21 2002-06-04 O'connor Lawrence Angioplasty catheter with transducer using balloon for focusing of ultrasonic energy and method for use
US9314298B2 (en) 2007-04-17 2016-04-19 St. Jude Medical, Atrial Fibrillation Divisions, Inc. Vacuum-stabilized ablation system
US6652547B2 (en) * 1999-10-05 2003-11-25 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using ultrasonic medical device operating in a transverse mode
US20040097996A1 (en) * 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
US20030236539A1 (en) * 1999-10-05 2003-12-25 Omnisonics Medical Technologies, Inc. Apparatus and method for using an ultrasonic probe to clear a vascular access device
US6551337B1 (en) 1999-10-05 2003-04-22 Omnisonics Medical Technologies, Inc. Ultrasonic medical device operating in a transverse mode
US6660013B2 (en) * 1999-10-05 2003-12-09 Omnisonics Medical Technologies, Inc. Apparatus for removing plaque from blood vessels using ultrasonic energy
US6733451B2 (en) 1999-10-05 2004-05-11 Omnisonics Medical Technologies, Inc. Apparatus and method for an ultrasonic probe used with a pharmacological agent
US6695782B2 (en) 1999-10-05 2004-02-24 Omnisonics Medical Technologies, Inc. Ultrasonic probe device with rapid attachment and detachment means
US6589253B1 (en) 1999-12-30 2003-07-08 Advanced Cardiovascular Systems, Inc. Ultrasonic angioplasty transmission wire
US6508781B1 (en) 1999-12-30 2003-01-21 Advanced Cardiovascular Systems, Inc. Ultrasonic ablation catheter transmission wire connector assembly
US6450975B1 (en) 1999-12-30 2002-09-17 Advanced Cardiovascular Systems, Inc. Ultrasonic transmission guide wire
US7166098B1 (en) 1999-12-30 2007-01-23 Advanced Cardiovascular Systems, Inc. Medical assembly with transducer for local delivery of a therapeutic substance and method of using same
US6494891B1 (en) 1999-12-30 2002-12-17 Advanced Cardiovascular Systems, Inc. Ultrasonic angioplasty transmission member
US6461383B1 (en) * 1999-12-30 2002-10-08 Advanced Cardiovascular Systems, Inc. Ultrasonic catheter vascular stent system and method
US7184827B1 (en) * 2000-01-24 2007-02-27 Stuart D. Edwards Shrinkage of dilatations in the body
WO2001087169A1 (en) * 2000-05-16 2001-11-22 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
WO2001095820A1 (en) 2000-06-13 2001-12-20 Atrionix, Inc. Surgical ablation probe for forming a circumferential lesion
US20040158317A1 (en) * 2000-07-18 2004-08-12 Pharmasonics, Inc. Coated stent with ultrasound therapy
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
US6416540B1 (en) 2000-11-01 2002-07-09 Sandip V. Mathur Magnetically actuated cleanable stent and method
US6740040B1 (en) * 2001-01-30 2004-05-25 Advanced Cardiovascular Systems, Inc. Ultrasound energy driven intraventricular catheter to treat ischemia
US7493162B2 (en) 2001-06-15 2009-02-17 Cardiac Pacemakers, Inc. Pulmonary vein stent for treating atrial fibrillation
US6554846B2 (en) 2001-09-28 2003-04-29 Scimed Life Systems, Inc. Sonic burr
US8974446B2 (en) * 2001-10-11 2015-03-10 St. Jude Medical, Inc. Ultrasound ablation apparatus with discrete staggered ablation zones
US7291110B2 (en) * 2001-10-12 2007-11-06 Boston Scientific Corporation Catheter lesion diagnostics
WO2003047439A2 (en) 2001-12-03 2003-06-12 Ekos Corporation Catheter with multiple ultrasound radiating members
US7141044B2 (en) 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
US7211055B2 (en) 2002-01-15 2007-05-01 The Regents Of The University Of California System and method providing directional ultrasound therapy to skeletal joints
WO2003061756A2 (en) * 2002-01-23 2003-07-31 The Regents Of The University Of California Implantable thermal treatment method and apparatus
WO2003068047A2 (en) * 2002-02-11 2003-08-21 Gold - T Tech, Inc. Method for preventing thrombus formation
US7236821B2 (en) * 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7153315B2 (en) * 2002-06-11 2006-12-26 Boston Scientific Scimed, Inc. Catheter balloon with ultrasonic microscalpel blades
US6855123B2 (en) 2002-08-02 2005-02-15 Flow Cardia, Inc. Therapeutic ultrasound system
US7758510B2 (en) 2003-09-19 2010-07-20 Flowcardia, Inc. Connector for securing ultrasound catheter to transducer
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US8808284B2 (en) 2008-09-26 2014-08-19 Relievant Medsystems, Inc. Systems for navigating an instrument through bone
US8613744B2 (en) 2002-09-30 2013-12-24 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US6907884B2 (en) 2002-09-30 2005-06-21 Depay Acromed, Inc. Method of straddling an intraosseous nerve
US6921371B2 (en) 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
EP1583569A4 (en) 2003-01-03 2009-05-06 Ekos Corp Ultrasonic catheter with axial energy field
US7604608B2 (en) * 2003-01-14 2009-10-20 Flowcardia, Inc. Ultrasound catheter and methods for making and using same
US6942677B2 (en) * 2003-02-26 2005-09-13 Flowcardia, Inc. Ultrasound catheter apparatus
US7258690B2 (en) 2003-03-28 2007-08-21 Relievant Medsystems, Inc. Windowed thermal ablation probe
US7220233B2 (en) 2003-04-08 2007-05-22 Flowcardia, Inc. Ultrasound catheter devices and methods
US20040230116A1 (en) * 2003-05-12 2004-11-18 Pharmasonics, Inc. Method and apparatus for detection of ultrasound transducer failure in catheter systems
US20050059993A1 (en) * 2003-09-17 2005-03-17 Kamal Ramzipoor Embolectomy device
US7335180B2 (en) 2003-11-24 2008-02-26 Flowcardia, Inc. Steerable ultrasound catheter
EP1713537A4 (en) 2004-01-29 2009-04-29 Ekos Corp Method and apparatus for detecting vascular conditions with a catheter
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
US7285116B2 (en) * 2004-05-15 2007-10-23 Irvine Biomedical Inc. Non-contact tissue ablation device and methods thereof
US20080200896A1 (en) * 2004-07-15 2008-08-21 Ascher Shmulewitz Device and Method for Treating a Blood Vessel
US7567841B2 (en) 2004-08-20 2009-07-28 Cardiac Pacemakers, Inc. Method and apparatus for delivering combined electrical and drug therapies
US7540852B2 (en) 2004-08-26 2009-06-02 Flowcardia, Inc. Ultrasound catheter devices and methods
MX2007002964A (en) * 2004-09-13 2008-03-05 Johnson & Johnson Ablation device with phased array ultrasound transducer.
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7617003B2 (en) 2005-05-16 2009-11-10 Cardiac Pacemakers, Inc. System for selective activation of a nerve trunk using a transvascular reshaping lead
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
AR054423A3 (en) * 2006-01-11 2007-06-27 Spinlock S R L An apparatus and method for measuring the flow rate and oil cut and water oil production time and actual flow
US9282984B2 (en) 2006-04-05 2016-03-15 Flowcardia, Inc. Therapeutic ultrasound system
US20070265560A1 (en) 2006-04-24 2007-11-15 Ekos Corporation Ultrasound Therapy System
WO2008031033A2 (en) * 2006-09-07 2008-03-13 Spence Paul A Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head
US8192363B2 (en) 2006-10-27 2012-06-05 Ekos Corporation Catheter with multiple ultrasound radiating members
US8246643B2 (en) 2006-11-07 2012-08-21 Flowcardia, Inc. Ultrasound catheter having improved distal end
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
ES2538110T3 (en) 2007-01-08 2015-06-17 Ekos Corporation Power parameters for ultrasonic catheter
GB0700560D0 (en) * 2007-01-11 2007-02-21 Emcision Ltd Device and method for the treatment of diseased tissue such as tumours
WO2008125145A1 (en) * 2007-04-13 2008-10-23 Synergio Ag A tissue penetration device and method
EP2164401B1 (en) * 2007-05-23 2015-08-26 Medinol Ltd. Apparatus for guided chronic total occlusion penetration
EP2170181B1 (en) 2007-06-22 2014-04-16 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
WO2009045265A1 (en) 2007-10-05 2009-04-09 Maquet Cardiovascular, Llc Devices and methods for minimally-invasive surgical procedures
US8939991B2 (en) 2008-06-08 2015-01-27 Hotspur Technologies, Inc. Apparatus and methods for removing obstructive material from body lumens
US20120109057A1 (en) 2009-02-18 2012-05-03 Hotspur Technologies, Inc. Apparatus and methods for treating obstructions within body lumens
US8945160B2 (en) 2008-07-03 2015-02-03 Hotspur Technologies, Inc. Apparatus and methods for treating obstructions within body lumens
US9101382B2 (en) 2009-02-18 2015-08-11 Hotspur Technologies, Inc. Apparatus and methods for treating obstructions within body lumens
JP5588978B2 (en) * 2008-07-27 2014-09-10 ピー・アイ−アール スクエアド エル・ティー・ディー Crushing of calcifications in heart valves
US8257378B1 (en) * 2008-07-28 2012-09-04 O'connor Lawrence R Ultrasonic guide wire for disintegration and dispersion of arterial occlusions of thrombi and plaque
US9005274B2 (en) * 2008-08-04 2015-04-14 Stentys Sas Method for treating a body lumen
EP3406210A1 (en) 2008-09-26 2018-11-28 Relievant Medsystems, Inc. Systems and for navigating an instrument through bone
US20100168741A1 (en) * 2008-12-29 2010-07-01 Hideo Sanai Surgical operation apparatus
US8226566B2 (en) 2009-06-12 2012-07-24 Flowcardia, Inc. Device and method for vascular re-entry
ES2503140T3 (en) 2009-07-03 2014-10-06 Ekos Corporation Power parameters for ultrasonic catheter
US20120215099A1 (en) * 2009-10-06 2012-08-23 Wallace Michael P Methods and Apparatus for Endovascular Ultrasound Delivery
US20110082414A1 (en) * 2009-10-06 2011-04-07 Wallace Michael P Ultrasound-enhanced stenosis therapy
US20110105960A1 (en) * 2009-10-06 2011-05-05 Wallace Michael P Ultrasound-enhanced Stenosis therapy
US9375223B2 (en) * 2009-10-06 2016-06-28 Cardioprolific Inc. Methods and devices for endovascular therapy
US20110082534A1 (en) * 2009-10-06 2011-04-07 Wallace Michael P Ultrasound-enhanced stenosis therapy
US20110082396A1 (en) * 2009-10-06 2011-04-07 Wallace Michael P Ultrasound-enhanced stenosis therapy
US8740835B2 (en) 2010-02-17 2014-06-03 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
JP5731965B2 (en) * 2011-12-27 2015-06-10 有限会社日本エレクテル Frequency heating balloon catheter
EP2882357A1 (en) 2012-08-08 2015-06-17 Shockwave Medical, Inc. Shockwave valvuloplasty with multiple balloons
EP2914186B1 (en) 2012-11-05 2019-03-13 Relievant Medsystems, Inc. Systems for creating curved paths through bone and modulating nerves within the bone
US20140180134A1 (en) * 2012-12-21 2014-06-26 Volcano Corporation Imaging catheter for imaging from within balloon
KR20150126611A (en) 2013-03-14 2015-11-12 에코스 코퍼레이션 Method and apparatus for drug delivery to a target site
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
JP2017502715A (en) * 2013-11-18 2017-01-26 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Thrombosis dispersion method and apparatus
US10092742B2 (en) 2014-09-22 2018-10-09 Ekos Corporation Catheter system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6527759B1 (en) * 1995-03-05 2003-03-04 Ekos Corporation Ultrasound assembly for use with light activated drugs

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3433226A (en) * 1965-07-21 1969-03-18 Aeroprojects Inc Vibratory catheterization apparatus and method of using
US3565062A (en) * 1968-06-13 1971-02-23 Ultrasonic Systems Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like
CA1237482A (en) * 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
EP0189329A3 (en) * 1985-01-25 1987-06-03 Robert E. Fischell A tunneling catheter system for transluminal arterial angioplasty
US4698058A (en) * 1985-10-15 1987-10-06 Albert R. Greenfeld Ultrasonic self-cleaning catheter system for indwelling drains and medication supply
US4948587A (en) * 1986-07-08 1990-08-14 Massachusetts Institute Of Technology Ultrasound enhancement of transbuccal drug delivery
US4808153A (en) * 1986-11-17 1989-02-28 Ultramed Corporation Device for removing plaque from arteries
US4870953A (en) * 1987-11-13 1989-10-03 Donmicheal T Anthony Intravascular ultrasonic catheter/probe and method for treating intravascular blockage
US5053044A (en) * 1988-01-11 1991-10-01 Devices For Vascular Intervention, Inc. Catheter and method for making intravascular incisions
US5163421A (en) * 1988-01-22 1992-11-17 Angiosonics, Inc. In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging
US4920954A (en) * 1988-08-05 1990-05-01 Sonic Needle Corporation Ultrasonic device for applying cavitation forces
US5458631A (en) * 1989-01-06 1995-10-17 Xavier; Ravi Implantable catheter with electrical pulse nerve stimulators and drug delivery system
US4936281A (en) * 1989-04-13 1990-06-26 Everest Medical Corporation Ultrasonically enhanced RF ablation catheter
JPH0363041A (en) * 1989-07-31 1991-03-19 Olympus Optical Co Ltd Ultrasonic therapeutic apparatus
US5344395A (en) * 1989-11-13 1994-09-06 Scimed Life Systems, Inc. Apparatus for intravascular cavitation or delivery of low frequency mechanical energy
US5085662A (en) * 1989-11-13 1992-02-04 Scimed Life Systems, Inc. Atherectomy catheter and related components
US5117831A (en) * 1990-03-28 1992-06-02 Cardiovascular Imaging Systems, Inc. Vascular catheter having tandem imaging and dilatation components
US5181920A (en) * 1990-06-08 1993-01-26 Devices For Vascular Intervention, Inc. Atherectomy device with angioplasty balloon and method
JPH05507226A (en) * 1990-06-15 1993-10-21
JPH07500523A (en) * 1992-08-28 1995-01-19
US5458568A (en) * 1991-05-24 1995-10-17 Cortrak Medical, Inc. Porous balloon for selective dilatation and drug delivery
US5197946A (en) * 1990-06-27 1993-03-30 Shunro Tachibana Injection instrument with ultrasonic oscillating element
US5279546A (en) * 1990-06-27 1994-01-18 Lake Region Manufacturing Company, Inc. Thrombolysis catheter system
US5269291A (en) * 1990-12-10 1993-12-14 Coraje, Inc. Miniature ultrasonic transducer for plaque ablation
US5324255A (en) * 1991-01-11 1994-06-28 Baxter International Inc. Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm
US5304115A (en) * 1991-01-11 1994-04-19 Baxter International Inc. Ultrasonic angioplasty device incorporating improved transmission member and ablation probe
US5267954A (en) * 1991-01-11 1993-12-07 Baxter International Inc. Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels
US5447509A (en) * 1991-01-11 1995-09-05 Baxter International Inc. Ultrasound catheter system having modulated output with feedback control
CA2063529A1 (en) * 1991-03-22 1992-09-23 Katsuro Tachibana Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
GB2258364A (en) * 1991-07-30 1993-02-03 Intravascular Res Ltd Ultrasonic tranducer
DE69224911D1 (en) * 1991-11-04 1998-04-30 Baxter Int Ultrasonic device for ablation with channel for guidewire
US5269297A (en) * 1992-02-27 1993-12-14 Angiosonics Inc. Ultrasonic transmission apparatus
US5380273A (en) * 1992-05-19 1995-01-10 Dubrul; Will R. Vibrating catheter
US5713848A (en) * 1993-05-19 1998-02-03 Dubrul; Will R. Vibrating catheter
US5672153A (en) * 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
US5362309A (en) * 1992-09-14 1994-11-08 Coraje, Inc. Apparatus and method for enhanced intravascular phonophoresis including dissolution of intravascular blockage and concomitant inhibition of restenosis
US5318014A (en) * 1992-09-14 1994-06-07 Coraje, Inc. Ultrasonic ablation/dissolution transducer
AT178218T (en) * 1993-02-05 1999-04-15 Joe W And Dorothy Dorsett Brow Ultrasonic balloon catheter for angioplasty
US5267985A (en) * 1993-02-11 1993-12-07 Trancell, Inc. Drug delivery by multiple frequency phonophoresis
US5462523A (en) * 1993-05-18 1995-10-31 Target Therapeutics, Inc. Drug delivery system
US5465725A (en) * 1993-06-15 1995-11-14 Hewlett Packard Company Ultrasonic probe
US5413107A (en) * 1994-02-16 1995-05-09 Tetrad Corporation Ultrasonic probe having articulated structure and rotatable transducer head
WO1995024159A1 (en) * 1994-03-07 1995-09-14 Medisonic A/S Apparatus for non-invasive tissue destruction by means of ultrasound
US5728123A (en) * 1995-04-26 1998-03-17 Lemelson; Jerome H. Balloon actuated catheter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6527759B1 (en) * 1995-03-05 2003-03-04 Ekos Corporation Ultrasound assembly for use with light activated drugs

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060058708A1 (en) * 2003-12-24 2006-03-16 Gill Heart Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue
US20070078505A1 (en) * 2005-04-05 2007-04-05 Dimitrov Nicolay G Two-balloon catheter device for coronary angioplasty and its use
US20090312827A1 (en) * 2005-12-23 2009-12-17 C.R. Bard Inc. Balloon catheter with centralized vent hole
US9849062B2 (en) 2007-05-16 2017-12-26 Chordate Medical Ab Vibration device
WO2008138997A1 (en) * 2007-05-16 2008-11-20 Rhinomed Ab Vibration device
US20100274164A1 (en) * 2007-05-16 2010-10-28 Rhinomed Ab Vibration device
US9579114B2 (en) 2008-05-07 2017-02-28 Northgate Technologies Inc. Radially-firing electrohydraulic lithotripsy probe
WO2009152352A3 (en) * 2008-06-13 2010-04-29 Aspen Medtech, Inc. Shockwave balloon catheter system
US20090312768A1 (en) * 2008-06-13 2009-12-17 Aspen Medtech, Inc. Shockwave balloon catheter system
US9072534B2 (en) 2008-06-13 2015-07-07 Shockwave Medical, Inc. Non-cavitation shockwave balloon catheter system
US20110166570A1 (en) * 2008-06-13 2011-07-07 Daniel Hawkins Shockwave balloon catheter system
US9011462B2 (en) 2008-06-13 2015-04-21 Shockwave Medical, Inc. Shockwave balloon catheter system
US8956374B2 (en) 2008-06-13 2015-02-17 Shockwave Medical, Inc. Shockwave balloon catheter system
US8956371B2 (en) 2008-06-13 2015-02-17 Shockwave Medical, Inc. Shockwave balloon catheter system
US10039561B2 (en) 2008-06-13 2018-08-07 Shockwave Medical, Inc. Shockwave balloon catheter system
US9180280B2 (en) 2008-11-04 2015-11-10 Shockwave Medical, Inc. Drug delivery shockwave balloon catheter system
US20100114065A1 (en) * 2008-11-04 2010-05-06 Daniel Hawkins Drug delivery shockwave balloon catheter system
US10149690B2 (en) 2008-11-05 2018-12-11 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US9044619B2 (en) 2008-11-05 2015-06-02 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US9044618B2 (en) 2008-11-05 2015-06-02 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US9421025B2 (en) 2008-11-05 2016-08-23 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US20100114020A1 (en) * 2008-11-05 2010-05-06 Daniel Hawkins Shockwave valvuloplasty catheter system
US20110034832A1 (en) * 2009-07-08 2011-02-10 Iulian Cioanta Usage of Extracorporeal and Intracorporeal Pressure Shock Waves in Medicine
US8556813B2 (en) 2009-07-08 2013-10-15 Sanuwave, Inc. Extracorporeal pressure shock wave device
US10238405B2 (en) 2009-07-08 2019-03-26 Sanuwave, Inc. Blood vessel treatment with intracorporeal pressure shock waves
US10058340B2 (en) 2009-07-08 2018-08-28 Sanuwave, Inc. Extracorporeal pressure shock wave devices with multiple reflectors and methods for using these devices
WO2012106259A2 (en) * 2011-02-04 2012-08-09 Daniel Hawkins High pressure balloon shockwave catheter and method
WO2012106259A3 (en) * 2011-02-04 2013-01-31 Daniel Hawkins High pressure balloon shockwave catheter and method
US9814476B2 (en) 2011-11-08 2017-11-14 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US8574247B2 (en) 2011-11-08 2013-11-05 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US9289224B2 (en) 2011-11-08 2016-03-22 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US8709075B2 (en) 2011-11-08 2014-04-29 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
US9198618B2 (en) 2011-12-16 2015-12-01 Chordate Medical Ab Pressure sensing system and method
US9782320B2 (en) 2011-12-16 2017-10-10 Chordate Medical Ab Double stimulation
US9895279B2 (en) 2011-12-16 2018-02-20 Chordate Medical Ab Stimulation of hypothalamus
US9579247B2 (en) 2011-12-16 2017-02-28 Chordate Medical Ab Treatment of headache disorders
US9486381B2 (en) 2011-12-16 2016-11-08 Chordate Medical Ab ALS treatment
US9451889B2 (en) 2011-12-16 2016-09-27 Chordate Medical Ab Pressure sensing system and method
US9872814B2 (en) 2012-03-20 2018-01-23 Chordate Medical Ag Vibration pattern for vibration stimulation
US9474684B2 (en) 2012-03-20 2016-10-25 Chordate Medical Ab Electroactive vibration method
US9642673B2 (en) 2012-06-27 2017-05-09 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
US9011463B2 (en) 2012-06-27 2015-04-21 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
US9993292B2 (en) 2012-06-27 2018-06-12 Shockwave Medical, Inc. Shock wave balloon catheter with multiple shock wave sources
US9433428B2 (en) 2012-08-06 2016-09-06 Shockwave Medical, Inc. Low profile electrodes for an angioplasty shock wave catheter
US10206698B2 (en) 2012-08-06 2019-02-19 Shockwave Medical, Inc. Low profile electrodes for an angioplasty shock wave catheter
US8747416B2 (en) 2012-08-06 2014-06-10 Shockwave Medical, Inc. Low profile electrodes for an angioplasty shock wave catheter
US9220521B2 (en) 2012-08-06 2015-12-29 Shockwave Medical, Inc. Shockwave catheter
US8888788B2 (en) 2012-08-06 2014-11-18 Shockwave Medical, Inc. Low profile electrodes for an angioplasty shock wave catheter
US9138249B2 (en) 2012-08-17 2015-09-22 Shockwave Medical, Inc. Shock wave catheter system with arc preconditioning
US9005216B2 (en) 2012-09-13 2015-04-14 Shockwave Medical, Inc. Shockwave catheter system with energy control
US9522012B2 (en) 2012-09-13 2016-12-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
US9333000B2 (en) 2012-09-13 2016-05-10 Shockwave Medical, Inc. Shockwave catheter system with energy control
US8728091B2 (en) 2012-09-13 2014-05-20 Shockwave Medical, Inc. Shockwave catheter system with energy control
US10159505B2 (en) 2012-09-13 2018-12-25 Shockwave Medical, Inc. Shockwave catheter system with energy control
US20140128963A1 (en) * 2012-11-02 2014-05-08 Medtronic, Inc. Transcatheter Valve Prosthesis Delivery System With Recapturing Feature and Method
US9675456B2 (en) * 2012-11-02 2017-06-13 Medtronic, Inc. Transcatheter valve prosthesis delivery system with recapturing feature and method
US9730715B2 (en) 2014-05-08 2017-08-15 Shockwave Medical, Inc. Shock wave guide wire
US10226265B2 (en) 2016-04-25 2019-03-12 Shockwave Medical, Inc. Shock wave device with polarity switching

Also Published As

Publication number Publication date
US20020188243A1 (en) 2002-12-12
US6287272B1 (en) 2001-09-11
JP2001500036A (en) 2001-01-09
AU4250897A (en) 1998-03-26
US5846218A (en) 1998-12-08
BR9712006A (en) 1999-08-24
EP1009298A1 (en) 2000-06-21
WO1998009571A1 (en) 1998-03-12
CA2260842A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
US8062566B2 (en) Method of manufacturing an ultrasound transmission member for use in an ultrasound catheter device
JP3231316B2 (en) Guide wire with a video capability
CN103037795B (en) The system uses RF energy recanalize an occluded vessel
EP0471764B1 (en) Instrument for intraluminally relieving stenosis
US5810767A (en) Method and apparatus for pressurized intraluminal drug delivery
US7335180B2 (en) Steerable ultrasound catheter
EP2298194B1 (en) Therapeutic ultrasound system
US7803168B2 (en) Aortic valve repair
CA2196237C (en) Vibrating stent for opening calcified lesions
CN102596320B (en) Methods percutaneous ultrasound to the treatment of hypertension and renal nerves means
EP1553996B1 (en) Ultrasound catheter for disrupting blood vessel obstructions
JP4805822B2 (en) Ultrasound systems for the treatment
US5429136A (en) Imaging atherectomy apparatus
US5938609A (en) Guidewire with imaging capability
JP4219558B2 (en) Embolectomy catheter for treating stroke and other small vessel thromboembolism
US5571086A (en) Method and apparatus for sequentially performing multiple intraluminal procedures
JP3629313B2 (en) Cutting the stenosis in a blood vessel of a patient and expanded to device
JP4223391B2 (en) Ultrasonic surgical instrument for the body waves photodynamic therapy
US8401667B2 (en) Selective accumulation of energy with or without knowledge of tissue topography
US6309355B1 (en) Method and assembly for performing ultrasound surgery using cavitation
US5695460A (en) Enhancement of ultrasound thrombolysis
JP3367666B2 (en) Vascular catheter having a distal end portion of the low profile
US7153315B2 (en) Catheter balloon with ultrasonic microscalpel blades
US6494874B1 (en) Methods and systems for the inhibition of vascular hyperplasia
US20100076299A1 (en) Inducing Desirable Temperature Effects On Body Tissue Using Alternate Energy Sources